Blog
RSS FeedPosted by Michael Wonder on 03 Mar 2016
Cancer drugs - the case for Keytruda
3 March 2016 - Is Pharmac’s decision not to prioritise funding melanoma drug Keytruda a case of “putting money before people”, ...
Posted by Michael Wonder on 03 Mar 2016
Great voice heard
3 March 2016 - The NZ Government has all but promised that a melanoma drug will be funded by Pharmac after ...
Posted by Michael Wonder on 02 Mar 2016
Tough choices in melanoma drug debate
2 March 2016 - Consider this, you're a multinational company peddling a relatively new melanoma cancer drug that's been effective for ...
Posted by Michael Wonder on 01 Mar 2016
Government's hands-off stance is fine - if people aren't dying
2 March 2016 - National is exposed on the issue of funding miracle melanoma drugs and it has only itself to ...
Posted by Michael Wonder on 01 Mar 2016
Plea to fund melanoma drug
2 March 2016 - Melanoma survivors, patients and supporters gathered in Wellington to present an 11,000-signature petition calling on the Government ...
Posted by Michael Wonder on 01 Mar 2016
New Zealand Pharmaceutical Schedule - 1 March 2016 update
1 March 2016 - the March 2016 issue of the Schedule sees the listing of a number of new medicines/combination ...
Posted by Michael Wonder on 29 Feb 2016
Tauranga woman fights for life-saving drug
1 March 2016 - Patients such as Tauranga's Leisa Renwick, who have had miraculous results with melanoma drugs, will join dying ...
Posted by Michael Wonder on 28 Feb 2016
Miracle' med too costly for patient
27 February 2016 - Tourette Syndrome sufferer distraught over inability to continue paying for life-changing Sativex prescription. ...
Posted by Michael Wonder on 26 Feb 2016
Medicines NZ calls for Government funding of melanoma wonder drug
26 February 2016 - Medicines NZ, a pharmaceutical company lobby group, say that the Pharmac model is broken and needs to ...
Posted by Michael Wonder on 22 Feb 2016
Supply of insulin glargine
22 February 2016 - PHARMAC invites proposals for the supply of insulin glargine in New Zealand. ...
Posted by Michael Wonder on 17 Feb 2016
Kaitaia woman's medical win
16 February 2016 - A Kaitaia woman is the first person in New Zealand to receive publicly-funded medical cannabis to control ...
Posted by Michael Wonder on 15 Feb 2016
PHARMAC invites proposals for the supply of various vaccines in New Zealand
15 February 2016 - PHARMAC is interested in considering any proposal from suppliers of various vaccines. ...
Posted by Michael Wonder on 12 Feb 2016
Approval of amendments to the listing of some respiratory products
12 February 2016 - PHARMAC is pleased to announce the approval of amendments to existing listing agreements with Novartis New Zealand ...
Posted by Michael Wonder on 11 Feb 2016
Summary of responses to PHARMAC’s consultation on improving access to medicines and devices in primary care
9 February 2016 - PHARMAC received feedback from a range of stakeholders including suppliers, wholesalers, general practice and their professional bodies ...
Posted by Michael Wonder on 09 Feb 2016
More treatments funded by PHARMAC for respiratory disease
9 February 2016 - PHARMAC is funding six new medicines that will improve treatment options for people with chronic obstructive pulmonary ...